Skip to main content
TipRanks
Go Ultimate75% OFF

iHuman (IH) AI Stock Analysis

96 Followers
IH

iHuman

(NYSE:IH)

Select Model
Rating:63Neutral
Price Target:$0.85â–¼(-0.93% Downside)
Action:reiterated
Date:11/19/26

The overall score of 63 reflects a company with a fortress-like balance sheet and seemingly compelling valuation, offset by significant operational and market headwinds. The primary strength is the company's financial stability, evidenced by negligible debt and a high equity base. The extremely low P/E ratio and high dividend yield are also major positive factors. However, these are counterbalanced by a clear downtrend in revenue and cash flow, which is confirmed by a very weak technical picture with the stock in a sustained downtrend. The company is profitable and financially safe, but the market is pricing in continued business contraction.

Positive Factors
Very strong balance sheetMinimal leverage and a substantial equity cushion give iHuman financial resilience through weaker operating periods. This reduces refinancing pressure, preserves flexibility to invest in products, and improves the company’s ability to withstand demand volatility without relying heavily on external funding.
Negative Factors
Revenue contractionDeclining revenue signals weakening demand or monetization across the existing business and makes future earnings growth less dependable. Continued contraction could reduce operating leverage, limit reinvestment capacity, and make the company more reliant on new products or international expansion to restore momentum.

iHuman (IH) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%IH-66.68%SPY+8.20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$8.92M
Dividend Yield
11.63%
Average Volume (3M)
7,907
Price to Earnings (P/E)
2.5
Beta (1Y)
0.31
Revenue Growth
-12.17%
EPS Growth
-78.28%
Country
US
Employees
558
Sector
Consumer Defensive
Sector Strength
62
Industry
Education & Training Services

iHuman Business Overview & Revenue Model

Company Description

Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions,...

iHuman Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is exceptionally strong (Score 92) with minimal debt and high equity, providing a solid foundation. However, the income statement (Score 48) and cash flow statement (Score 52) show declining revenues and weakening cash generation. The overall financial health is stable but challenged by a two-year contraction in top-line growth.

Income Statement

48Neutral

Balance Sheet

92Very Positive

Cash Flow

52Neutral
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Mar 2023Dec 2021
Income Statement
Total Revenue752.48M807.02M922.20M1.02B985.52M944.72M
Gross Profit501.39M547.61M640.15M721.27M691.17M660.62M
EBITDA8.97M109.54M124.26M214.26M143.60M-30.78M
Net Income23.96M95.40M98.59M180.91M109.82M-37.05M
Balance Sheet
Total Assets1.24B1.37B1.42B1.45B1.33B1.10B
Cash, Cash Equivalents and Short-Term Investments1.01B1.15B1.17B1.21B1.05B855.36M
Total Debt8.33M11.38M14.91M3.86M9.02M34.25M
Total Liabilities411.65M373.42M458.80M492.69M563.95M492.51M
Stockholders Equity832.18M995.80M960.85M957.80M769.45M608.37M
Cash Flow
Free Cash Flow045.15M51.10M165.61M1.25B5.93M
Operating Cash Flow049.92M58.55M172.12M1.29B38.21M
Investing Cash Flow039.45M-52.76M-6.51M-225.03M-31.95M
Financing Cash Flow0-54.56M-102.28M-9.45M-47.66M410.00K

iHuman Technical Analysis

Technical Analysis SentimentNegative
Last Price0.86

Price Trends

50DMA1.13Negative
100DMA1.23Negative
200DMA1.44Negative

Market Momentum

MACD-0.07Positive
RSI35.06Neutral
STOCH20.55Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IH, the sentiment is Negative. The current price of 0.86 is below the 20-day moving average (MA) of 1.09, below the 50-day MA of 1.13, and below the 200-day MA of 1.44, indicating a bearish trend. The MACD of -0.07 indicates Positive momentum. The RSI at 35.06 is Neutral, neither overbought nor oversold. The STOCH value of 20.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IH.

iHuman Risk Analysis

iHuman disclosed 87 risk factors in its most recent earnings report. iHuman reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.We incurred net losses in the past, and we may not be able to remain profitable or increase profitability in the future.Q4, 2023
2.If we are unable to manage our growth effectively, our business and prospects may be materially and adversely affected.Q4, 2023
3.Uncertainties with respect to the legal system in mainland China, including uncertainties regarding the interpretation and enforcement of laws, regulations and policies of mainland China, could adversely affect us. As the legal system of mainland China is evolving, laws, regulations and rules in mainland China may change quickly with little advance notice, which may subject us to non-compliance due to unexpected changes to the laws, regulations and rules applicable to us.Q4, 2023

iHuman Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

IH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TALTAL73Outperform$4.83B2.4819.00%―25.56%350.25%
EDUEDU72Outperform$8.31B16.2012.52%3.04%20.74%41.78%
IHIH63Neutral$43.96M2.452.54%11.63%-12.17%-78.28%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
GOTUGOTU58Neutral$535.92M-16.67-26.92%―24.86%48.69%
YQYQ54Neutral$28.41M-1.61-39.66%―80.33%31.05%
COECOE45Neutral$61.82M-0.0652.88%―74.92%-149.51%

* Consumer Defensive Sector Average

Performance Comparison

-75%-50%-25%0%25%IHEDUCOETALGOTUYQDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IHIhuman Inc.0.86-1.77-67.28%
EDUNew Oriental Education & Technology52.603.286.65%
COEChina Online Education Group10.33-31.74-75.45%
TALTAL Education10.02-1.08-9.73%
GOTUGaotu Techedu Inc.2.28-0.37-13.96%
YQ17 Education & Technology Group, Inc.2.62-2.42-48.02%

iHuman Corporate Events

iHuman Posts Q2 2026 Loss as China Demographics Weigh, Bets on AI and Global Expansion

Sep 29, 2026

iHuman Inc., listed on the NYSE, is a Beijing-based provider of tech-powered knowledge and personal growth products, with a strong focus on children’s education and English literacy. The company operates a portfolio of learning apps and IP-driven con...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026